Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer.

Authors:
Dr. Bora Lim, MD
Dr. Bora Lim, MD
University of Texas MD anderson cancer center
Assistant Professor
Breast Medical Oncology
Houston, TEXAS | United States

Breast Cancer Res Treat 2014 Jun 13;145(3):615-23. Epub 2014 May 13.

Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea.

The clinical behavior of human epidermal growth factor 2 (HER2)-positive breast cancer, including pathologic complete response rate and pattern of relapse and metastasis, differs substantially according to hormone receptor (HR) status. We investigated various histopathologic features of HER2-positive breast cancer and their correlation with HR status. We retrospectively analyzed tumors of 450 HER2-positive breast cancer patients treated with chemotherapy and 1 year of trastuzumab. HR-/HER2+ tumors showed higher nuclear grade, less tubule formation, higher histologic grade, frequent apocrine features, diffuse and abundant lymphocytic infiltration, strong HER2 immunohistochemical staining (3+), higher average HER2 copy number and HER2/CEP17 ratio, the absence of HER2 genetic heterogeneity, and greater p53 expression than HR+/HER2+ tumors. An inverse correlation was observed between estrogen receptor or progesterone receptor Allred score and average HER2 copy number or HER2/CEP17 ratio. The percentage of ductal carcinoma in situ (DCIS) within the tumor was negatively correlated with ER Allred score, but positively correlated with average HER2 copy number and HER2/CEP17 ratio. Pathologic tumor size and DCIS percentage also showed a significant inverse correlation. Ratio of metastatic to total examined lymph node number was significantly correlated with average HER2 copy number and HER2/CEP17 ratio. High pT stage (hazard ratio, 2.370; p = 0.027), the presence of lymphovascular invasion (hazard ratio, 2.806; p = 0.005), and HR negativity (hazard ratio, 2.202; 1.074-4.513; p = 0.031) were found to be independent prognostic indicators of poor disease-free survival. In conclusion, HR+/HER2+ and HR-/HER2+ breast cancer showed distinct histopathologic features that may be relevant to their distinct clinical behavior.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2983-xDOI Listing
June 2014
41 Reads
8 Citations
3.940 Impact Factor

Publication Analysis

Top Keywords

breast cancer
20
copy number
16
her2 copy
16
average her2
16
her2-positive breast
16
number her2/cep17
16
her2/cep17 ratio
16
hazard ratio
12
histopathologic features
8
clinical behavior
8
correlated average
8
inverse correlation
8
allred score
8
ratio
8
her2
6
number
5
breast
5
cancer
5
higher average
4
tumors
4

References

(Supplied by CrossRef)

CM Perou et al.
Nature 2000

Cancer Genome Atlas N et al.
Nature 2012

JM Harvey et al.
J Clin Oncol 1999

M Morrow et al.
Breast 2013

YH Park et al.
Cancer Chemother Pharmacol 2010

H Sihto et al.
Breast Cancer Res 2011

G Konecny et al.
J Natl Cancer Inst 2003

ME Hammond et al.
J Oncol Pract 2010

AC Wolff et al.
Arch Pathol Lab Med 2013

H Seol et al.
Mod Pathol 2012

G Pekar et al.
Cancer 2013

Similar Publications